DBVT Q2 2017 Earnings — DBV Technologies S.A. Revenue & Financial Results | Market Cap Arena

DBVTDBV Technologies S.A.

$538M

Q2 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$4M+48.3% YoY

Gross Profit

$4M100.0% margin

Operating Income

-$41M-1111.4% margin

Net Income

-$41M-1133.8% margin

EPS (Diluted)

$-8.40

QoQ Revenue Growth

+7.0%

Cash Flow

Operating Cash Flow

-$32M

Free Cash Flow

-$34M

Stock-Based Comp.

$11M

Balance Sheet

Total Assets

$310M

Total Liabilities

$60M

Stockholders' Equity

$250M

Cash & Equivalents

$259M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4M	$2M	+48.3%
Gross Profit	$4M	$2M	+48.3%
Operating Income	-$41M	-$27M	-48.1%
Net Income	-$41M	-$27M	-50.9%